Women who take a popular class of antidepressants during pregnancy may be risking the health of their developing fetus, and the risk may outweigh any benefit to the mother, a new review of data suggests. According to new …
Targeted News Service – Oct. 31, 2012 Harvard Medical School issued the following news release Elevated risk of miscarriage, preterm birth, neonatal health comp.
The debate over the safety of antidepressants during pregnancy has been going on for a long time, and a new review may keep the debate alive a while longer.
(NaturalNews) Big Pharma wants pregnant women to take prescription drugs, vaccine shots and even chemotherapy. It's the latest insanity from an industry that kills more Americans ever year than died in the entire Vietnam …
Researchers have learned that antidepressants could increase the risk of multiple birth complications if taken by pregnant women.
Exposure to selective serotonin reuptake inhibitors is associated with an increased risk of intracerebral and intracranial hemorrhage, according to a study published online Oct. 17 in Neurology.
Priligy belongs to the drug class of selective serotonin reuptake inhibitors (SSRI). It is short-acting, quickly absorbed and eliminated in the body that is why it is not used as an antidepressant, but is effective as a premature ejaculation treatment.
Nearly a third of newborns born to mothers who took selective serotonin reuptake inhibitors develop a condition called “newborn behavioral syndrome” that causes jitteriness, feeding problems, and inconsolable crying during …
Investigators of the review concluded that selective serotonin reuptake inhibitor (SSRI) antidepressants should be prescribed “with great caution” during pregnancy. They point to studies that have linked SSRI in pregnancy to …
Abstract. Objective: We synthesized the epidemiologic evidence concerning selective serotonin reuptake inhibitor (SSRI) exposure and the risk of CNS hemorrhage. Methods: We searched for controlled observational studies …
The actual study, The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond (Domar, Moragianni, Ryley & Urato, 2012) has been …
Selective serotonin reuptake inhibitors (SSRI) may be outliving its welcome as a drug of choice for depression, anxiety disorder and other personality disorders. The drug has always been widely controversial to researchers …
Elevated risk of miscarriage, preterm birth, neonatal health complications and possible longer term neurobehavioral abnormalities, including autism, suggest that a class of antidepressants known as selective serotonin reuptake inhibitors …